Trethera (Formerly Triangle Therapeutics)

Trethera (Formerly Triangle Therapeutics)

Small molecules that control dna replication and integrity.

Launch date
Employees
Market cap
-
Enterprise valuation
£22—34m (Dealroom.co estimates Feb 2016.)
Beverly Hills California (HQ)
Authorizing premium user...